Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

NCT02441803 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Busulfan
DRUG: Fludarabine
DRUG: Clofarabine
RADIATION: Total Body Irradiation (TBI)
DRUG: Thymoglobulin
BIOLOGICAL: Stem Cell Infusion
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: Decitabine
DRUG: Cytarabine
DRUG: Idarubicin

Sponsor

M.D. Anderson Cancer Center